Nanotechnology in Stroke: New Trails with Smaller Scales
Sign Up to like & getrecommendations! Published in 2023 at "Biomedicines"
DOI: 10.3390/biomedicines11030780
Abstract: Stroke is a leading cause of death, long-term disability, and socioeconomic costs, highlighting the urgent need for effective treatment. During acute phase, intravenous administration of recombinant tissue plasminogen activator (tPA), a thrombolytic agent, and endovascular… read more here.
Keywords: time window; nanotechnology; agent; stroke new ... See more keywords